News

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...
Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...
While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...